GlycoMimetics Inc.

(GLYC) Trade

By |

Profile

GlycoMimetics Inc is a clinical stage biotechnology company. It is engaged in discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.

Contact Information

Website: www.glycomimetics.com
Email: info@glycomimetics.com.
Main Phone: +1 240 243-1201
Address: 9708 Medical Center Drive
Address 2: Suite 1700
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NSD
CEO: Rachel K. King
Employees: 40
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 14.43 $ 0.25 (1.76%)
Last Price 14.43 Change $ 0.25 Change % 1.76 Tick N/A
Bid N/A Bid Size 0.00 Ask 14.45 Ask Size 1,000.00
Open 14.21 High 14.52 Low 14.19 Prev Close 14.18
Last Trade Volume 136,656 52 Wk Hi 26.05 52 Wk Low 10.25
Market Cap 621.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 43,057,267.00 EPS (TTM) -1.10 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 23 25
Number of Buys 8 8
Number of Sells 15 17
Net Activity -42702 -46702
Last 10 Buys Shares
Daniel M. Junius 1,000
Mark A. Goldberg 1,000
Michael A. Henos 1,000
Michael A. Henos 1,000
Last 10 Sell Shares
Brian M. Hahn 1,000
Peter J. Barris 1,000
Peter J. Barris 1,000
M. James Barrett 1,000
Sandell D Scott 1,000
Sandell D Scott 1,000
M. James Barrett 1,000
Helen M. Thackray 1,000
Helen M. Thackray 1,000
Helen M. Thackray 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 35 35 35 35
Low Target Price Estimate 21 21 21 21
Mean Target Price Estimate 28.25 28.25 28.25 28.25
Standard Deviation 6.4 6.4 6.4 6.4
Date of Most Recent Estimate 05/31/18 05/03/18 05/03/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1